/Mafias

The Eli Lilly Mafia

73 people came through Eli Lilly and went on to found or lead other companies.

Jonathan P. NorthrupVP, Business development & StrategyFounded Beta Cat Pharmaceuticals +2Paul F. TruexManagerFounded Lqttrx +2Dirk ReynSales ManagerFounded Spectricity +1Scott ByrdUS and Global Brand Leader - Cardiovascular and Critical CareFounded Outpost Medicine +1Jacopo LeonardiNew Product Planning ManagerFounded 4D Path +1Kevin JudiceSenior Vice President, Lilly Research Laboratories, and CEO of DICE TherapeuticsFounded DiCE Molecules +1Justin WisemanAssoc. Analytical ChemistFounded Prosolia, Inc. +1Stacy LindborgQuantitative Pharmacology, Board MemberFounded BrainStorm Cell Therapeutics +1Howard BermanMedical AffairsFounded Coya Therapeutics +1Steve CarchediDirector Oncology Product Group- Global Oncology Franchise LeaderFounded Cornerstone Pharmaceuticals +1Martin BablervariousFounded Alumis +1Matt TindallSpecialty Sales Representative, Women's HealthFounded FlightPath +1Michael KalosChief Scientific Officer, Cancer Immunobiology, Distinguished Lilly ScholarFounded IpiNovyx BioCarolyn ZhouMBA Intern, US HCO Strategy and MarketingFounded Tomorrow HealthParis PanayiotopoulosGM Leadership ProgramFounded AvenCellRobert BalfourSourcing AssociateFounded Pro MatixBrian FarmerGlobal Marketing AssociateFounded InipharmChristopher WhitfieldCEO and General ManagerFounded Antigenix TherapeuticsJoe Cook JrGroup Vice PresidentFounded Ironwood PharmaceuticalsAman BrarConsultant - Corporate Financial PlanningFounded JobviteDonmienne LeungSenior Research ScientistFounded ThirtyFiveBio LimitedLuigi CostaHead of Global Access and Pricing (CNS)Founded Noema PharmaMike BolinderDirector, Lean Six Sigma, Demand RealizationFounded Acacia PharmaJen AsherR&D Associate, Biotherapeutics Discovery ResearchFounded 1910Amar KumarPortfolio Manager / Systems AnalystFounded KaiPod LearningBeth HoffmanHead, NeuroscienceFounded Origami Therapeutics, Inc.Derek YeBioinformatics EngineerFounded MaximalPari LatawaAI Research InternFounded Illume LabsDanyal AhmadAutomation EngineerFounded TwolabsAaron EdwardsGenetic Medicine- External Partnership & Academic Collaborations-InternFounded KiraGen BioPiyush AgarwalData Science SpecialistFounded ReoElisabet de los PinosBrand Manager Oncology Business UnitFounded Aura BiosciencesDiana CaldwellDistrict Sales ManagerFounded Amplified SciencesJim SchulzSenior Financial AnalystFounded Scioto BiosciencesMatt KawieckiManufacturing InternFounded TotchopEric EasomUS Brand Manager, Endcrine Business Unit and HumatropeFounded AN2 TherapeuticsCarsten BrunnGlobal Product TeamFounded Cartesian Therapeutics (NASDAQ: RNAC)EVAN SUSSMANDiabetes CareFounded Granata BioSteven JamesDepartment Head, InternationalFounded Pionyr ImmunotherapeuticsEmily ColmanSales RepresentativeFounded RonanRx Inc.Mike BurnsSummer Intern – Early Phase Pharmaceutical Research and DesignFounded Decimal CodeDipal DoshiHead, Oncology Healthcare Services for Lilly Ventures | Senior Associate, Oncology Marketing GroupFounded Entrada Therapeutics, Inc.Nathan HubbardDirector, Oncology & Hematology Corporate Finance & Investment BankingFounded Flatiron HealthSona ShahEngineer/ Technical Services RepresentativeFounded NeopendaWa'el HashadBusiness Unit Leader cardiovascular business unitFounded LongeveronJohn RiggSenior Director MS&TFounded NanoImaging ServicesKaren WursterSr. Director, US Marketing, Diabetes PortfolioFounded Adipo TherapeuticsMartin A. BrennerSenior Research ScientistFounded iBioDavid MarekSales and MarketingFounded ReAlta Life SciencesAaron SchachtExecutive Director - R&D Strategy, Portfolio and Project ManagementFounded BiomEditJoanna WolakNeuroinflammation Group LeaderFounded EndLyz TherapeuticsDonald CorcoranMgmt/Staff Positions of progressive responsibilites in 9 years at Eli Lilly and CompanyFounded Cyteir TherapeuticsSridhar BankuruBI ConsultantFounded RightDataBRIAN STUGLIKVice President and Chief Marketing Officer, Oncology Global MarketingFounded VerastemAnn Lee-KarlonManager, New Ventures (Chorus)Founded Epi BiologicsStuart HughesPrincipal Research ScientistFounded Pathios TherapeuticsRick BrunoCommercial Operations DirectorFounded Openi AnalyticsSankar LaguduIT leadFounded ResponsiveRachel HumphreyVice President, Head of Immuno-OncologyFounded NormunityDave HaaseSenior Brand ConsultantFounded JunoNaruby SchlenkerFinancial AnalystFounded OrdoroPaul V. RadspinnerVarious Management Roles in Sales, Marketing, Business DevelopmentFounded FluGenUlrik SørensenEli Lilly, IndianapolisFounded Acesion Pharma ApSNicola SandersonLean Six Sigma Black Belt - productivity improvement specialistFounded EscavoxDovydas VerikasAssistant to Sales & Marketing Manager for Baltic countriesFounded LigenceRick StrawAssociate ConsultantFounded PACIVJorge L. RodriguezProcess Control EngineerFounded PACIVBabatunde IloriIntern - Marketing AssociateFounded Parsec EducationRobert S. SchultzCorp. Training & Development/Managed Care Neuroscience Specialty Rep. & Institutional CoordinatorFounded Direct AllergyOlivier TaelmanSales And Marketing SpecialistFounded NyxoahJames Posada, Ph.D.Manager, Biotechnology R&DFounded Resolve TherapeuticsJingye ZhouAssociate DirectorFounded EccogeneChulho ParkResearch AdvisorFounded Oncotelic Therapeutics

Frequently asked questions

What is the Eli Lilly mafia?
The Eli Lilly mafia is the network of 73 people who came through Eli Lilly and went on to found or lead other companies, including Beta Cat Pharmaceuticals, Lqttrx, Spectricity, Outpost Medicine, 4D Path.
Who is in the Eli Lilly mafia?
Notable members include Jonathan P. Northrup (Beta Cat Pharmaceuticals), Paul F. Truex (Lqttrx), Dirk Reyn (Spectricity), Scott Byrd (Outpost Medicine), Jacopo Leonardi (4D Path), Kevin Judice (DiCE Molecules), Justin Wiseman (Prosolia, Inc.), Stacy Lindborg (BrainStorm Cell Therapeutics), among 73 tracked members.
What companies did Eli Lilly alumni found?
Companies founded by Eli Lilly alumni include Beta Cat Pharmaceuticals, Lqttrx, Spectricity, Outpost Medicine, 4D Path, DiCE Molecules, Prosolia, Inc., BrainStorm Cell Therapeutics, Coya Therapeutics, Cornerstone Pharmaceuticals.